These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15998773)

  • 1. Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness.
    Guarino V; Faviana P; Salvatore G; Castellone MD; Cirafici AM; De Falco V; Celetti A; Giannini R; Basolo F; Melillo RM; Santoro M
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5270-8. PubMed ID: 15998773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autocrine stimulation by osteopontin plays a pivotal role in the expression of the mitogenic and invasive phenotype of RET/PTC-transformed thyroid cells.
    Castellone MD; Celetti A; Guarino V; Cirafici AM; Basolo F; Giannini R; Medico E; Kruhoffer M; Orntoft TF; Curcio F; Fusco A; Melillo RM; Santoro M
    Oncogene; 2004 Mar; 23(12):2188-96. PubMed ID: 14981541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between calcification and bone sialoprotein and osteopontin in papillary thyroid carcinoma.
    Wu G; Guo JJ; Ma ZY; Wang J; Zhou ZW; Wang Y
    Int J Clin Exp Pathol; 2015; 8(2):2010-7. PubMed ID: 25973097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
    Yu XM; Lo CY; Chan WF; Lam KY; Leung P; Luk JM
    Clin Cancer Res; 2005 Nov; 11(22):8063-9. PubMed ID: 16299237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intercellular adhesion molecule-1 (ICAM-1) is upregulated in aggressive papillary thyroid carcinoma.
    Buitrago D; Keutgen XM; Crowley M; Filicori F; Aldailami H; Hoda R; Liu YF; Hoda RS; Scognamiglio T; Jin M; Fahey TJ; Zarnegar R
    Ann Surg Oncol; 2012 Mar; 19(3):973-80. PubMed ID: 21879273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ret/PTC expression may be associated with local invasion of thyroid papillary carcinoma.
    Miki H; Kitaichi M; Masuda E; Komaki K; Yamamoto Y; Monden Y
    J Surg Oncol; 1999 Jun; 71(2):76-81; discussion 81-2. PubMed ID: 10389862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell carcinomas and enhances carcinoma cell proliferation and invasiveness.
    Celetti A; Testa D; Staibano S; Merolla F; Guarino V; Castellone MD; Iovine R; Mansueto G; Somma P; De Rosa G; Galli V; Melillo RM; Santoro M
    Clin Cancer Res; 2005 Nov; 11(22):8019-27. PubMed ID: 16299231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible relation of osteopontin to development of psammoma bodies in human papillary thyroid cancer.
    Tunio GM; Hirota S; Nomura S; Kitamura Y
    Arch Pathol Lab Med; 1998 Dec; 122(12):1087-90. PubMed ID: 9870857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator activated receptor gamma immunohistochemical expression in human papillary thyroid carcinoma tissues. Possible relationship to lymph node metastasis.
    Galusca B; Dumollard JM; Chambonniere ML; Germain N; Prades JM; Péoc'h M; Estour B
    Anticancer Res; 2004; 24(3b):1993-7. PubMed ID: 15274390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.
    Xu X; Quiros RM; Gattuso P; Ain KB; Prinz RA
    Cancer Res; 2003 Aug; 63(15):4561-7. PubMed ID: 12907632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.
    Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG
    Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.
    Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS
    J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin-a splice variant is overexpressed in papillary thyroid carcinoma and modulates invasive behavior.
    Ferreira LB; Tavares C; Pestana A; Pereira CL; Eloy C; Pinto MT; Castro P; Batista R; Rios E; Sobrinho-Simões M; Gimba ER; Soares P
    Oncotarget; 2016 Aug; 7(32):52003-52016. PubMed ID: 27409830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant overexpression of pyruvate kinase M2 is associated with aggressive tumor features and the BRAF mutation in papillary thyroid cancer.
    Feng C; Gao Y; Wang C; Yu X; Zhang W; Guan H; Shan Z; Teng W
    J Clin Endocrinol Metab; 2013 Sep; 98(9):E1524-33. PubMed ID: 23846818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of RET/PTC expression in papillary thyroid carcinoma and its correlation with prognostic factors in a north Indian population.
    Mishra A; Agrawal V; Krishnani N; Mishra SK
    J Postgrad Med; 2009; 55(3):171-5. PubMed ID: 19884740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression and role of serum response factor in papillary carcinoma of the thyroid.
    Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
    Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylated c-Jun NH2-terminal kinase is overexpressed in human papillary thyroid carcinomas and associates with lymph node metastasis.
    Wang X; Chao L; Zhen J; Chen L; Ma G; Li X
    Cancer Lett; 2010 Jul; 293(2):175-80. PubMed ID: 20138424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIN1, a critical component of the mTOR-Rictor complex, is overexpressed and associated with AKT activation in medullary and aggressive papillary thyroid carcinomas.
    Moraitis D; Karanikou M; Liakou C; Dimas K; Tzimas G; Tseleni-Balafouta S; Patsouris E; Rassidakis GZ; Kouvaraki MA
    Surgery; 2014 Dec; 156(6):1542-8; discussion 1548-9. PubMed ID: 25456951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas.
    Castellone MD; Guarino V; De Falco V; Carlomagno F; Basolo F; Faviana P; Kruhoffer M; Orntoft T; Russell JP; Rothstein JL; Fusco A; Santoro M; Melillo RM
    Oncogene; 2004 Aug; 23(35):5958-67. PubMed ID: 15184868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of ret/PTC-1 rearrangements in neoplastic thyroid tissue using TaqMan RT-PCR.
    Sheils OM; O'Leary JJ; Sweeney EC
    J Pathol; 2000 Sep; 192(1):32-6. PubMed ID: 10951397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.